Cargando…

Case Report: Bupropion Reduces the [(123)I]FP-CIT Binding to Striatal Dopamine Transporter

The diagnosis of parkinsonian syndromes in patients with severe depression may be challenging due to overlapping clinical phenomena, especially regarding psychomotor and affective symptoms. [(123)I]FP-CIT-SPECT is a useful method to detect degenerative parkinsonian disorders. However, some drugs may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milenkovic, Ivan, Bartova, Lucie, Papageorgiou, Konstantinos, Kasper, Siegfried, Traub-Weidinger, Tatjana, Winkler, Dietmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937912/ https://www.ncbi.nlm.nih.gov/pubmed/33692710 http://dx.doi.org/10.3389/fpsyt.2021.631357

Ejemplares similares

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Effects of l-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat
por: Nikolaus, Susanne, et al.
Publicado: (2013)

Intranasal Dopamine Reduces In Vivo [(123)I]FP-CIT Binding to Striatal Dopamine Transporter: Correlation with Behavioral Changes and Evidence for Pavlovian Conditioned Dopamine Response
por: de Souza Silva, Maria A., et al.
Publicado: (2016)

Lower (123)I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies
por: Joling, Merijn, et al.
Publicado: (2018)

Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal (123)I-FP-CIT indices
por: Nicastro, Nicolas, et al.
Publicado: (2019)

Responsivity of the Striatal Dopamine System to Methylphenidate—A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
por: Aster, Hans-Christoph, et al.
Publicado: (2022)

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
por: Thomsen, Gerda, et al.
Publicado: (2013)

Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018)

Imaging of dopamine transporters in Parkinson disease: a meta‐analysis of (18)F/(123)I‐FP‐CIT studies
por: Kong, Yanyan, et al.
Publicado: (2020)

Imaging of serotonin transporters with [(123)I]FP-CIT SPECT in the human hypothalamus
por: Borgers, Anke J, et al.
Publicado: (2013)

Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism
por: Solla, Paolo, et al.
Publicado: (2015)

Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
por: Thomas, Alan J., et al.
Publicado: (2017)

Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT
por: Matsuda, Hiroshi, et al.
Publicado: (2018)

Computer-aided diagnosis for ((123)I)FP-CIT imaging: impact on clinical reporting
por: Taylor, Jonathan Christopher, et al.
Publicado: (2018)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
por: D’agostino, G., et al.
Publicado: (2023)

[(123)I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods
por: Tossici-Bolt, Livia, et al.
Publicado: (2017)

Diagnostic value of micrographia in Parkinson’s disease: a study with [(123)I]FP-CIT SPECT
por: Eklund, Mikael, et al.
Publicado: (2022)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

Intrasubject relationship between striatal (18)F-FP-CIT uptake and cardiac (123)I-MIBG uptake differs by motor subtype in early Parkinson disease
por: Jang, Wooyoung, et al.
Publicado: (2021)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis
por: Rahman, Mahmudur G. M., et al.
Publicado: (2018)

A Novel Automatic Approach for Calculation of the Specific Binding Ratio in [I-123]FP-CIT SPECT
por: Rahman, Mahmudur G. M., et al.
Publicado: (2020)

(123)I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies
por: Pardini, Matteo, et al.
Publicado: (2020)

Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
por: Park, So Hyeon, et al.
Publicado: (2019)

Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An (123)I-FP-CIT SPECT study
por: Joling, Merijn, et al.
Publicado: (2019)

Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study
por: De Feo, Maria Silvia, et al.
Publicado: (2023)

(123)I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component
por: Garriga, Marina, et al.
Publicado: (2015)

Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT
por: Nonokuma, Masanari, et al.
Publicado: (2016)

Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
por: Jeong, Eun Hye, et al.
Publicado: (2018)

Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data
por: Jeong, Eun Hye, et al.
Publicado: (2022)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [(123)I]I-FP-CIT SPECT in routine practice
por: Chahid, Youssef, et al.
Publicado: (2023)

[(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2022)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [(123)I]FP-CIT SPECT imaging
por: Dickson, John C., et al.
Publicado: (2017)

Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dopaminergic system neurodegeneration
por: Akahoshi, Miho, et al.
Publicado: (2017)

Comparison of machine learning and semi-quantification algorithms for (I123)FP-CIT classification: the beginning of the end for semi-quantification?
por: Taylor, Jonathan Christopher, et al.
Publicado: (2017)

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An (123)I-FP-CIT SPECT study
por: van der Zande, J.J., et al.
Publicado: (2019)

β-Amyloid PET and (123)I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia
por: Chen, Qin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_860bgv1nrj1568ncu5hg0k9pc8